Mycrodose Therapeutics Receives US DEA Schedule I License to Research Four (4) Psychedelic Compounds
San Diego, California (PRWEB) August 20, 2021 -- Mycrodose Therapeutics is pleased to announce that the company has been approved by the United States Drug
Source: prweb.com